Amex Ventures and Citi Ventures were among the returning investors that backed the identity verification software provider in its series D round, at a $1.75bn valuation.

Humana and Cox Enterprises are set to exit the primary care provider in an all-share acquisition by publicly listed peer One Medical.

Novel Group and CAA are set to exit NuOrder after the business-to-business e-commerce platform agreed to an acquisition by Lightspeed.

Mayo Clinic returned to reinvest in the genomics platform developer three years after backing its series B round alongside Illumina.

Returning investor Mitsubishi has joined fellow corporates BHP Group and Freeport-McMoRan for a round that increased the copper extraction technology provider's total funding to $100m.

SoftBank is set to exit smart scheduling software developer X.ai as its Vision Fund 2 invests in artificial intelligence technology unicorn AInnovation.

BMW i Ventures, Dell Technologies Capital and Robert Bosch Venture Capital are in line to exit the manufactiuring services marketplace, which has filed for a $100m offering.

Noria Therapeutics and PSMA Therapeutics have both been acquired by Bayer, which will integrate their respective assets into its own oncology portfolio.

The low Earth orbit mapping technology provider has raised more than $100m altogether, having picked up series A financing from Weru Investment in 2018.

The Johnson & Johnson, GlaxoSmithKline and DaVita HealthCare Partners-backed medical device producer is looking to raise $75m in an offering on the Nasdaq Global Market.